Summit's precision antibiotic ridinilazole is in a phase 3 clinical trial
Summit Therapeutics
Human Longevity Inc
Pharmacyclics
Intuitive Surgical
Computer Motion
Metropolis Media
Communication Machinery Company
Government Technology Services
Paradise Bakery
Sunset Designs